As of the end of fiscal year 2024, Tracenable has captured detailed data on Hansoh Pharmaceutical Group's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group.a
The dataset includes information on 5 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to Hansoh Pharmaceutical Group's consolidated operations.a
Tracenable's data also records the effective ownership percentages that Hansoh Pharmaceutical Group holds across these entities, providing transparency into its corporate control, ownership hierarchy, and group governance practices.a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.a | CHN | Subsidiary | 100% | ||
Shanghai Hansoh Biomedical Co., Ltd.a | CHN | Subsidiary | 100% | ||
Hansoh Pharma International Limiteda | HKG | Subsidiary | 100% | ||
Hansoh (Shanghai) Healthtech Co., Ltd.a | CHN | Subsidiary | 100% | ||
Changzhou Hansoh Pharmaceutical Co., Ltd.a | CHN | Subsidiary | 100% |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
Tracenable's group entities dataset provides geographic insights into Hansoh Pharmaceutical Group's significant subsidiaries, revealing their location around the world.a
In total, the Hansoh Pharmaceutical Group group includes 5 significant subsidiaries distributed across 2 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure.a
This visualization highlights the geographical distribution of Hansoh Pharmaceutical Group's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.a
In 2024, Tracenable identified that the Hansoh Pharmaceutical Group group consisted of5 significant subsidiaries, located across 2 countries.a
This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network.a
Hansoh Pharmaceutical Group's significant subsidiaries are primarily located in Asia, which together host 100% of its material entities.a
This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.
Hansoh Pharmaceutical Group exhibits a limited level of transparency concerning its corporate ownership structure.
The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance.a
Without full group hierarchy or equity details, it offers a restricted view of Hansoh Pharmaceutical Group's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.
No. Tracenable's data does not indicate any entities registered in jurisdictions typically categorized as low-tax or offshore financial centers, suggesting that Hansoh Pharmaceutical Group's ownership network is primarily domiciled in standard corporate jurisdictions or that Hansoh Pharmaceutical Group does not provide full transparency on its corporate structure.a